<産業資料/調査レポートの題名> 2022年7月17日

世界のフローサイトメトリー市場:技術別(セルベース、ビーズベース)、製品別(分析装置、選別機、試薬、消耗品、ソフトウェア)、エンドユーザー別(アカデミア、研究所、病院、臨床研究所、Pharma-Biotech Cos)、用途別


◆英文タイトル:Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents, Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos), Application - Global Forecasts to 2025

1 Introduction (Page No. – 24)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Stakeholders
2 Research Methodology (Page No. – 28)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Estimation Methodology
2.2.1 Revenue Mapping-Based Market Estimation
2.2.2 Usage-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation Methodology
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary (Page No. – 37)
4 Premium Insights (Page No. – 42)
4.1 Flow Cytometry: Market Overview
4.2 Flow Cytometry Products & Services Market, 2019 vs. 2025
4.3 Market, By Application, 2019 vs. 2025
4.4 Market, By End User, 2019 vs. 2025
4.5 Geographical Snapshot of the Market
5 Market Overview (Page No. – 46)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements
5.2.1.2 Increasing Incorporation of Ai Platforms in Flow Cytometry Workflows and Advancements in Flow Cytometry Software
5.2.1.3 Growing Adoption of Flow Cytometry Techniques in Research and Academia
5.2.1.4 Growing Public-Private Initiatives in the Field of Immunology and Immuno-Oncology Research
5.2.1.5 Rising Global Incidence and Prevalence of Hiv/Aids and Cancer
5.2.1.6 Increased Availability of Application-Specific Products
5.2.2 Restraints
5.2.2.1 Significant Product Costs
5.2.2.2 Limited Purchasing Power of End Users in Emerging Countries
5.2.3 Opportunities
5.2.3.1 Growing Market Presence in Emerging Countries
5.2.3.2 Evolving Pipeline for Stem Cell Research
5.2.3.3 Adoption of Recombinant Dna Technology for Antibody Production
5.2.3.4 Evolution of Tandem Flow Cytometry Technologies
5.2.4 Challenges
5.2.4.1 Inadequate Infrastructure for Research in Emerging Countries
5.2.4.2 Complexities Related to Reagent Development
5.2.4.3 Dearth of Well-Trained and Skilled Professionals
5.3 Regulatory Challenges
5.3.1 Stringent Fda Requirements
5.3.2 Stringent Analyte-Specific Reagent Rule
5.3.3 Lack of Well-Defined Validation Protocols for Cell-Based Assays
5.3.4 Absence of Established Laboratory-Developed Test Guidelines on Cell-Based Fluorescence Assays
5.3.5 Greater Global Recognition for Ivd–Ce Mark Approvals
5.4 US Reimbursement Scenario
6 Flow Cytometry Market, By Technology (Page No. – 61)
6.1 Introduction
6.2 Cell-Based Flow Cytometry
6.2.1 Research & Development on Novel Therapeutic Agents Will Drive the Growth of the Cell-Based Market
6.3 Bead-Based Flow Cytometry
6.3.1 Procedural Advantages of Bead-Based Flow Cytometry Have Driven Market Growth
7 Flow Cytometry Market, By Product & Service (Page No. – 66)
7.1 Introduction
7.2 Reagents & Consumables
7.2.1 Reagents and Consumables Will Generate the Highest Revenue in the Flow Cytometry Market During the Forecast Period
7.3 Flow Cytometry Instruments
7.3.1 Cell Analyzers
7.3.1.1 High-Range Cell Analyzers
7.3.1.1.1 High-Range Cell Analyzers Account for the Largest Share of the Cell Analyzers Market
7.3.1.2 Mid-Range Cell Analyzers
7.3.1.2.1 Wide Availability of Compact and High-Performance Analyzers in This Price Range Support Market Growth
7.3.1.3 Low-Range Cell Analyzers
7.3.1.3.1 Low-Range Analyzers Find Significant Adoption Among Price-Sensitive End Users
7.3.2 Cell Sorters
7.3.2.1 High-Range Cell Sorters
7.3.2.1.1 High-Range Cell Sorters Dominate the Market
7.3.2.2 Mid-Range Cell Sorters
7.3.2.2.1 Product Launches and the Cost-Efficiency of Mid-Range Sorters Have Enabled the Growth of This Market Segment
7.3.2.3 Low-Range Cell Sorters
7.3.2.3.1 Increasing Commercialization of Affordable Products has Driven the Adoption of Low-Range Cell Sorters
7.4 Services
7.4.1 Custom Flow Cytometry Assay Development Services Have Helped in the Advancement of Research, Especially in Cell Biology
7.5 Software
7.5.1 Availability of A Wide Range of Analysis Software and Advancements are Driving Market Growth
7.6 Accessories
8 Flow Cytometry Market, By Application (Page No. – 95)
8.1 Introduction
8.2 Research Applications
8.2.1 Pharmaceuticals & Biotechnology
8.2.1.1 Drug Discovery
8.2.1.1.1 Wide Usage of Flow Cytometry in Drug Discovery is the Primary Driver of Market Growth
8.2.1.2 Stem Cell Research
8.2.1.2.1 Accuracy and Precision of Flow Cytometry Have Made It A Prominent Tool in Stem Cell Research
8.2.1.3 In Vitro Toxicity Testing
8.2.1.3.1 Need to Reduce Time and Cost of Drug Development Processes Will Be A Key Factor Driving Market Growth
8.2.2 Immunology
8.2.2.1 Flow Cytometry Plays A Vital Role in Immunology Studies
8.2.3 Cell Sorting
8.2.3.1 Increase in Cell-Based Research Activity has Boosted Growth in This Application Segment
8.2.4 Apoptosis
8.2.4.1 Flow Cytometry Techniques are Used to Identify Changes Occurring During Apoptosis
8.2.5 Cell Cycle Analysis
8.2.5.1 Any Abnormality in Dna Content Can Be Detected Using Flow Cytometry
8.2.6 Cell Viability
8.2.6.1 Cell Viability is A Key Parameter Studied Using Flow Cytometry
8.2.7 Cell Counting
8.2.7.1 Flow Cytometry Allows for Easy Differentiation of Cells Via Scattering Or Staining
8.2.8 Other Research Applications
8.3 Clinical Applications
8.3.1 Cancer
8.3.1.1 Cancer Applications Include the Determination of Tumor Malignancy and Chromosome Enumeration
8.3.2 Hematology
8.3.2.1 Flow Cytometry Can Help Identify A Wide Variety of Cell Surfaces and Cytoplasmic Antigens
8.3.3 Immunodeficiency Diseases
8.3.3.1 Flow Cytometry Allows for Simultaneous, Multi-Parametric Cell Analysis
8.3.4 Organ Transplantation
8.3.4.1 Use of Flow Cytometry to Reduce Organ Rejection Rates has Contributed to Market Growth
8.3.5 Other Clinical Applications
8.4 Industrial Applications
8.4.1 Wide End-User Base Will Drive Market Growth
9 Flow Cytometry Market, By End User (Page No. – 115)
9.1 Introduction
9.2 Academic & Research Institutes
9.2.1 Growing Number of Research Projects Through Industry-Academia Collaborations to Drive Market Growth
9.3 Hospitals & Clinical Testing Laboratories
9.3.1 Rising Awareness and Disease Prevalence Have Sustained the Demand for Flow Cytometry in Hospitals
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Increase in Drug Discovery Activities to Drive Market Growth
10 Flow Cytometry Market, By Region (Page No. – 121)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Technological Innovation and Strategic Collaborations are the Key Drivers of Market Growth in the US
10.2.2 Canada
10.2.2.1 Availability of Public and Private Funding for Research Activities Will Boost Demand for Flow Cytometry Products in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Strong R&D Infrastructure and Training and Awareness Programs Have Ensured Market Growth in Germany
10.3.2 UK
10.3.2.1 UK to Witness Growing Acceptance of Flow Cytometry Products for Clinical Diagnostics
10.3.3 France
10.3.3.1 Training and Awareness Programs By Social Organizations and Key Players are Expected to Fuel the Adoption of Flow Cytometry
10.3.4 Italy
10.3.4.1 Growing Use of Clinical Flow Cytometry Will Favor Market Growth
10.3.5 Spain
10.3.5.1 High Instrument Costs and Funding Limitations Have Slowed Market Growth in Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Strong Infrastructure and Favorable Market Outlook Have Sustained Japan’s Dominance in the APAC Market
10.4.2 China
10.4.2.1 China Accounts for the Second-Largest Share of the APAC Market
10.4.3 India
10.4.3.1 High Incidence of Hiv/Aids and Cancer Drives Demand for Flow Cytometry Instruments in India
10.4.4 Australia
10.4.4.1 Rise in Cancer Prevalence and Awareness on Flow Cytometry Have Favored the Growth of the Australian Market
10.4.5 South Korea
10.4.5.1 Rising Awareness and the Growing Presence of Players are Driving Market Growth
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.1.1 Brazil Dominates the Latam Market for Flow Cytometry
10.5.2 Mexico
10.5.2.1 Free Trade Agreements Will Support Imports and Accessibility to Flow Cytometry Instruments in Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 Low Disposable Income and Need for Infrastructural Development Hinder Market Growth
11 Competitive Landscape (Page No. – 182)
11.1 Introduction
11.2 Competitive Leadership Mapping
11.3 Competitive Leadership Mapping: Major Market Players (2018)
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Companies
11.4 Competitive Leadership Mapping: Emerging Companies/Smes/Start-Ups (2018)
11.4.1 Progressive Companies
11.4.2 Starting Blocks
11.4.3 Responsive Companies
11.4.4 Dynamic Companies
11.5 Competitive Scenario (2016–2019)
11.5.1 Key Product Launches and Approvals (2016–2019)
11.5.2 Key Agreements, Partnerships, and Collaborations (2016–2019)
11.5.3 Key Acquisitions (2016–2019)
11.5.4 Key Expansions (2016–2019)
11.6 Global Market Share Analysis, Top Three Market Players (2018)
12 Company Profiles (Page No. – 192)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Becton, Dickinson and Company
12.2 Beckman Coulter (A Subsidiary of Danaher)
12.3 Thermo Fisher Scientific
12.4 Merck KGaA
12.5 Luminex Corporation
12.6 Agilent Technologies
12.7 Sony Biotechnology (A Subsidiary of Sony Corporation of America)
12.8 Bio-Rad Laboratories
12.9 Miltenyi Biotec
12.10 Enzo Life Sciences, Inc. (A Subsidiary of Enzo Biochem)
12.11 Sysmex Partec (A Subsidiary of Sysmex Corporation)
12.12 Biomérieux SA
12.13 Cytonome/St, LLC
12.14 Stratedigm, Inc.
12.15 Apogee Flow Systems
12.16 Cytek Biosciences, Inc.
12.17 Other Companies
12.17.1 Sartorius AG
12.17.2 Union Biometrica, Inc.
12.17.3 Nanocellect Biomedical, Inc.
12.17.4 On-Chip Biotechnologies Co., Ltd.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 240)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark